Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Autor: Bausch B; Department of Medicine II, Freiburg University Medical Center, Albert-Ludwigs University, Freiburg, Germany., Schiavi F; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Ni Y; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Welander J; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden., Patocs A; Second Department of Medicine, Semmelweis University, Budapest, Hungary.; Molecular Medicine Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary., Ngeow J; Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Wellner U; Department of Surgery, University of Lübeck, Lübeck, Germany., Malinoc A; Department of Nephrology and General Medicine, University Medical Center, Albert-Ludwigs University, Freiburg, Germany., Taschin E; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Barbon G; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Lanza V; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Söderkvist P; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden., Stenman A; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden., Larsson C; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden., Svahn F; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital Stockholm, Stockholm, Sweden., Chen JL; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Marquard J; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Fraenkel M; Department of Medicine, Endocrinology, and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Walter MA; Institute of Nuclear Medicine, University Hospital, Bern, Switzerland., Peczkowska M; Department of Hypertension, Institute of Cardiology, Warsaw, Poland., Prejbisz A; Department of Hypertension, Institute of Cardiology, Warsaw, Poland., Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Hasse-Lazar K; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland., Petersenn S; Center for Endocrine Tumors, Hamburg, Germany., Moeller LC; Department of Endocrinology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany., Meyer A; Department of Endocrinology, Helios Klinikum, Erfurt, Germany., Reisch N; Department of Endocrinology, Ludwigs-Maximilians University of Munich, Munich, Germany., Trupka A; Department of Surgery, City Hospital, Starnberg, Germany., Brase C; Department of Otorhinolaryngology, University of Erlangen, Erlangen, Germany., Galiano M; Department of Pediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany., Preuss SF; Department of Otolaryngology, University of Cologne, Cologne, Germany., Kwok P; Department of Otorhinolaryngology, University of Regensburg, Regensburg, Germany., Lendvai N; Molecular Medicine Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary., Berisha G; Department of Nephrology and General Medicine, University Medical Center, Albert-Ludwigs University, Freiburg, Germany., Makay Ö; Division of Endocrine Surgery, Department of General Surgery, Ege University, Izmir, Turkey., Boedeker CC; Department of Otolaryngology, HELIOS Hanseklinikum Stralsund, Stralsund, Germany., Weryha G; Department of Endocrinology, University of Nancy, Nancy, France., Racz K; Second Department of Medicine, Semmelweis University, Budapest, Hungary., Januszewicz A; Department of Hypertension, Institute of Cardiology, Warsaw, Poland., Walz MK; Department of Surgery and Center of Minimally Invasive Surgery, Kliniken Essen-Mitte, Essen, Germany., Gimm O; Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.; Department of Surgery, Region Östergötland, Linköping, Sweden., Opocher G; Veneto Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Eng C; Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Neumann HPH; Section for Preventive Medicine, University Medical Center, Albert-Ludwigs University, Freiburg, Germany.

Publikováno v: JAMA oncology [JAMA Oncol] 2017 Sep 01; Vol. 3 (9), pp. 1204-1212.